Brokerages Set $4.75 Target Price for Prima BioMed Ltd (NASDAQBMD)
Posted by Scott Davis on May 2nd, 2016 // No Comments
Shares of Prima BioMed Ltd (NASDAQ
BMD) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the four analysts that provide coverage for the stock, Zacks Investment Research reports. Four investment analysts have rated the stock with a strong buy rating. Prima BioMed’s rating score has improved by 40.1% from three months ago as a result of various analysts’ upgrades and downgrades.
Brokerages have set a 12 month consensus target price of $4.75 for the company, according to Zacks. Zacks has also given Prima BioMed an industry rank of 160 out of 265 based on the ratings given to its competitors.
The New moviment .....and i see SMA 200 near.we must destroy it
- Forums
- ASX - By Stock
- NASDAQ
Brokerages Set $4.75 Target Price for Prima BioMed Ltd...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add IMM (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 133736 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.355 |
2 | 9500 | 0.350 |
4 | 199315 | 0.345 |
10 | 84868 | 0.340 |
2 | 10985 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 96182 | 4 |
0.365 | 81517 | 4 |
0.370 | 150545 | 8 |
0.375 | 156434 | 4 |
0.380 | 167642 | 11 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |